CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Search results
>
Research work
<em>piggyBac</em> transposition reprograms fibroblasts to induced pluripotent stem cells
Authors
A Meissner
A Nagy
+40 more
A Nagy
Andras Nagy
D Huangfu
G Belteki
Hoon-Ki Sung
Iacovos P. Michael
J Cadinanos
J Ellis
JB Kim
K Kaji
K Okita
K Okita
K Takahashi
K Takahashi
Keisuke Kaji
Knut Woltjen
LC Cary
M Stadtfeld
M Stadtfeld
M Wernig
Maria Mileikovsky
Marina Gertsenstein
MH Wilson
MJ Fraser
N Maherali
Paria Mohseni
Pentao Liu
R Mitra
Rebecca Cowling
Ridham Desai
Riikka Hämäläinen
S Agha-Mohammadi
S Ding
SC Wu
T Brambrink
TH Dafa’alla
TS Mikkelsen
W Wang
Wei Wang
Y Fujiwara
Publication date
1 January 2009
Publisher
'Springer Science and Business Media LLC'
Doi
View
on
PubMed
Abstract
Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2) is sufficient to reprogram somatic cells to a pluripotent state. The resulting induced pluripotent stem (iPS) cells resemble embryonic stem cells in their properties and potential to differentiate into a spectrum of adult cell types. Current reprogramming strategies involve retroviral, lentiviral, adenoviral and plasmid transfection to deliver reprogramming factor transgenes. Although the latter two methods are transient and minimize the potential for insertion mutagenesis, they are currently limited by diminished reprogramming efficiencies. piggyBac (PB) transposition is host-factor independent, and has recently been demonstrated to be functional in various human and mouse cell lines. The PB transposon/transposase system requires only the inverted terminal repeats flanking a transgene and transient expression of the transposase enzyme to catalyse insertion or excision events. Here we demonstrate successful and efficient reprogramming of murine and human embryonic fibroblasts using doxycycline-inducible transcription factors delivered by PB transposition. Stable iPS cells thus generated express characteristic pluripotency markers and succeed in a series of rigorous differentiation assays. By taking advantage of the natural propensity of the PB system for seamless excision, we show that the individual PB insertions can be removed from established iPS cell lines, providing an invaluable tool for discovery. In addition, we have demonstrated the traceless removal of reprogramming factors joined with viral 2A sequences delivered by a single transposon from murine iPS lines. We anticipate that the unique properties of this virus-independent simplification of iPS cell production will accelerate this field further towards full exploration of the reprogramming process and future cell-based therapies. © 2009 Macmillan Publishers Limited. All rights reserved.Link_to_subscribed_fulltex
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Edinburgh Research Explorer
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pure.ed.ac.uk:publications...
Last time updated on 08/02/2015
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 26/02/2019
HKU Scholars Hub
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:hub.hku.hk:10722/249030
Last time updated on 21/11/2017
Edinburgh Research Explorer
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:pure.ed.ac.uk:openaire/a25...
Last time updated on 20/11/2025